1. Home
  2. VRNA vs NVMI Comparison

VRNA vs NVMI Comparison

Compare VRNA & NVMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VRNA
  • NVMI
  • Stock Information
  • Founded
  • VRNA 2005
  • NVMI 1993
  • Country
  • VRNA United Kingdom
  • NVMI Israel
  • Employees
  • VRNA N/A
  • NVMI N/A
  • Industry
  • VRNA Biotechnology: Pharmaceutical Preparations
  • NVMI Electronic Components
  • Sector
  • VRNA Health Care
  • NVMI Technology
  • Exchange
  • VRNA Nasdaq
  • NVMI Nasdaq
  • Market Cap
  • VRNA 8.3B
  • NVMI 6.9B
  • IPO Year
  • VRNA 2017
  • NVMI 2000
  • Fundamental
  • Price
  • VRNA $105.18
  • NVMI $263.55
  • Analyst Decision
  • VRNA Buy
  • NVMI Strong Buy
  • Analyst Count
  • VRNA 11
  • NVMI 5
  • Target Price
  • VRNA $114.10
  • NVMI $282.50
  • AVG Volume (30 Days)
  • VRNA 8.1M
  • NVMI 279.7K
  • Earning Date
  • VRNA 08-11-2025
  • NVMI 08-07-2025
  • Dividend Yield
  • VRNA N/A
  • NVMI N/A
  • EPS Growth
  • VRNA N/A
  • NVMI 53.04
  • EPS
  • VRNA N/A
  • NVMI 6.63
  • Revenue
  • VRNA $118,535,000.00
  • NVMI $743,954,000.00
  • Revenue This Year
  • VRNA $893.95
  • NVMI $30.96
  • Revenue Next Year
  • VRNA $73.76
  • NVMI $7.00
  • P/E Ratio
  • VRNA N/A
  • NVMI $39.60
  • Revenue Growth
  • VRNA N/A
  • NVMI 41.03
  • 52 Week Low
  • VRNA $18.51
  • NVMI $154.00
  • 52 Week High
  • VRNA $105.50
  • NVMI $291.99
  • Technical
  • Relative Strength Index (RSI)
  • VRNA 70.25
  • NVMI 48.95
  • Support Level
  • VRNA $104.58
  • NVMI $254.62
  • Resistance Level
  • VRNA $105.31
  • NVMI $277.70
  • Average True Range (ATR)
  • VRNA 0.22
  • NVMI 9.26
  • MACD
  • VRNA -0.64
  • NVMI -3.55
  • Stochastic Oscillator
  • VRNA 60.49
  • NVMI 28.42

About VRNA Verona Pharma plc

Verona Pharma PLC is a clinical-stage biopharmaceutical company focused on developing and commercializing therapeutics for the treatment of respiratory diseases with unmet medical needs. The company is currently focusing on developing its Ensifentrine product candidate, which will treat chronic obstructive pulmonary disease (COPD), cystic fibrosis (CF), and other respiratory diseases, including asthma.

About NVMI Nova Ltd.

Nova Ltd is a semiconductor equipment manufacturer. The company provides metrology solutions for process control used in semiconductor manufacturing. The company offers in-line optical and x-ray stand-alone metrology systems, as well as integrated optical metrology systems. The product range consists of Nova 2040, Nova 3090Next, Nova i500 and i500 Plus, Nova T500, Nova T600, Nova V2600, HelioSense 100, Nova Hybrid Metrology solution, NovaMars. The company generates the majority of its revenue from China. Geographically the company has its business spread across the region of Taiwan, Korea, China, the United States, and Europe.

Share on Social Networks: